Jason Williamson

1

• Jason Williamson
• jasonw_at_ometric.com
• 803.467.1571
• April 2005

2
Corporate Background

• Spin-out of University of South Carolina
  Nanocenter
• Revolutionary spectroscopy sensor technology
• 10 years of research 5 Million in federal
  funding
• Comprehensive patent portfolio
• Seed investment from Trelys in February 2005

3
The First 60 Days

• Assembled 8 core team members
• Identified multiple large market opportunities
• Selected pharma as initial target market
• Won 2 SBIR grants (from NSF and DOD)
• Closed large order with top 3 pharma company

4
Highly Talented and Experienced Team

• Jason Williamson, 35
• CEO, multiple successful startups
• VP, SC Technology Alliance
• Forty under Forty business leader
• Dr. Michael Myrick, 42
• Professor of Chemistry, USC
• Staff, Lawrence Livermore
• Inventor, Multivariate Optical Computing
• Scott Means, 34
• Microsoft Development Labs
• Founder, Enterprise Web Machines
• XML Expert, bestselling author
• Dr. John Blackburn, 40
• Entrepreneur, Federal Grant Expert
• PhD, Chemical Engineering

• Dr. Robert Freese, 50
• U.S. Distinguished Inventor of the Year for CD-RW
  technology
• CEO, multiple successful startups
• PhD, Optical Engineering
• Jon James, 27
• MS, Advanced Materials (under Dr. John Ballato,
  Clemson University)
• Dr. John Palms, 68
• Former President, USC
• Chair, Institute for Defense Analysis
• Chandler Prof. of Physics, Emory
• Robert Fletcher, 35
• Principal, The Trelys Funds
• CEO, Washington state startup
• Harvard MBA, Controls Engineer

5
Revolutionary Core Technology

• Known as Multivariate Optical Computing
• Solves limitations of current spectroscopy
  technology
• Enables real-time analysis of complex chemical
  compounds via a small, rugged sensor
• Brings spectroscopy out of the lab

6
Markets Applications
Pharmaceutical
Chemical Industrial
Drug Manufacturing, Quality Control Drug
Discovery
Homeland Security
Explosives detection Biological agents
Oil gas sensors Water quality Pollution
Food Agribusiness
Medical
Cancer cell detection In Situ Cell
Analysis Skin Cancer
Remotecrop sensing Bacteria, quality control
7
Initial Target Market Big Pharma

• Half trillion dollar industry
• Quality Control is 1 problem
• Very few real-time quality control sensors used
  today in drug manufacturing
• Over 1,000 drugs recalled in last 5 years, most
  due to poor manufacturing quality
• FDA stepping up quality control requirements
• Ometric provides key solution
• First order from top 3 pharmaceutical company
• Every pharmaceutical company has this problem

8
Technology In Use Today

• Lab spectrometers are the current alternative
• Very expensive
• Very complex
• Designed for the lab
• Conventional spectrometer vendors focused on lab
  market

9
Potential Partners

• Process control vendors have the sales channel,
  but lack spectroscopy solutions that the
  pharmaceutical industry is demanding

10
Intellectual Property Other Assets

• Multiple patents issued, multiple pending
• Over 10 years of trade secrets, know-how and
  software inventory
• Exclusive, worldwide, perpetual license with
  University of South Carolina
• Access rights to 5 Million in proprietary lab
  equipment at USC Nanocenter

11
Ometric PL ForecastProjections for
pharmaceutical market only
12
Business Opportunity Summary

• Experienced and talented team of successful
  entrepreneurs and scientists
• Breakthrough technology is proprietary and
  protected
• Meets huge unmet needs in multiple industries
• Pharmaceutical market is generating revenues
  today
• Raising 3 million A-round, with Trelys as lead
  investor

13

• Jason Williamson
• jasonw_at_ometric.com
• 803.467.1571
• April 2005